Mechanistic intersections of empagliflozin and nebivolol in aging-associated redox and inflammatory pathways

Mohammed Akram Al-Mahdawi, Hayder Adnan Fawzi, Nurul'Izzah Ibrahim, Norliza Muhammad

Open source

DOI
10.3389/fphar.2026.1842207
Published
2026-07-16
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1842207,
  title = {Mechanistic intersections of empagliflozin and nebivolol in aging-associated redox and inflammatory pathways},
  author = {Mohammed Akram Al-Mahdawi and Hayder Adnan Fawzi and Nurul'Izzah Ibrahim and Norliza Muhammad},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1842207},
  url = {https://doi.org/10.3389/fphar.2026.1842207}
}

RIS

TY  - JOUR
TI  - Mechanistic intersections of empagliflozin and nebivolol in aging-associated redox and inflammatory pathways
AU  - Mohammed Akram Al-Mahdawi
AU  - Hayder Adnan Fawzi
AU  - Nurul'Izzah Ibrahim
AU  - Norliza Muhammad
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1842207
UR  - https://doi.org/10.3389/fphar.2026.1842207
ER  - 

APA

Al-Mahdawi, M. A., Fawzi, H. A., Ibrahim, N., & Muhammad, N. (2026). Mechanistic intersections of empagliflozin and nebivolol in aging-associated redox and inflammatory pathways. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1842207

Source records